These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Pharmacophore-guided fragment-based design of novel mammalian target of rapamycin inhibitors: extra precision docking, fingerprint-based 2D and atom-based 3D-QSAR modelling. Kumar A; Rai S; Rathi E; Agarwal P; Kini SG J Biomol Struct Dyn; 2021 Mar; 39(4):1155-1173. PubMed ID: 32037974 [TBL] [Abstract][Full Text] [Related]
8. A computer-aided drug design approach to explore novel type II inhibitors of c-Met receptor tyrosine kinase for cancer therapy: QSAR, molecular docking, ADMET and molecular dynamics simulations. Daoui O; Nour H; Abchir O; Elkhattabi S; Bakhouch M; Chtita S J Biomol Struct Dyn; 2023; 41(16):7768-7785. PubMed ID: 36120976 [TBL] [Abstract][Full Text] [Related]
9. Computational modelling studies of some 1,3-thiazine derivatives as anti-influenza inhibitors targeting H1N1 neuraminidase via 2D-QSAR, 3D-QSAR, molecular docking, and ADMET predictions. Abdullahi M; Uzairu A; Shallangwa GA; Mamza PA; Ibrahim MT Beni Suef Univ J Basic Appl Sci; 2022; 11(1):104. PubMed ID: 36000144 [TBL] [Abstract][Full Text] [Related]
10. Development of novel monoamine oxidase B (MAO-B) inhibitors by combined application of docking-based alignment, 3D-QSAR, ADMET prediction, molecular dynamics simulation, and MM_GBSA binding free energy. El Aissouq A; Chedadi O; Bouachrine M; Ouammou A; Khalil F J Biomol Struct Dyn; 2023 Jul; 41(10):4667-4680. PubMed ID: 35510607 [TBL] [Abstract][Full Text] [Related]
11. Design of novel anti-cancer drugs targeting TRKs inhibitors based 3D QSAR, molecular docking and molecular dynamics simulation. Er-Rajy M; El Fadili M; Mujwar S; Zarougui S; Elhallaoui M J Biomol Struct Dyn; 2023; 41(21):11657-11670. PubMed ID: 36695085 [TBL] [Abstract][Full Text] [Related]
15. Identification of potential inhibitors for HCV NS5b of genotype 4a by combining dynamic simulation, protein-ligand interaction fingerprint, 3D pharmacophore, docking and 3D QSAR. El-Hassab MAE; El-Bastawissy EE; El-Moselhy TF J Biomol Struct Dyn; 2020 Sep; 38(15):4521-4535. PubMed ID: 31647392 [TBL] [Abstract][Full Text] [Related]
16. In silico research on new sulfonamide derivatives as BRD4 inhibitors targeting acute myeloid leukemia using various computational techniques including 3D-QSAR, HQSAR, molecular docking, ADME/Tox, and molecular dynamics. Belghalia E; Ouabane M; El Bahi S; Rehman HM; Sbai A; Lakhlifi T; Bouachrine M J Biomol Struct Dyn; 2024 Oct; 42(17):9201-9219. PubMed ID: 37656159 [TBL] [Abstract][Full Text] [Related]
17. Molecular Docking, G-QSAR Studies, Synthesis and Anticancer Screening of Some New 2-Phenazinamines as Bcr-Abl Tyrosine Kinase Inhibitors. Kale MA; Sonwane GM Curr Drug Discov Technol; 2020; 17(2):213-224. PubMed ID: 30210004 [TBL] [Abstract][Full Text] [Related]
18. Insight parameter drug design for human β-tryptase inhibition integrated molecular docking, QSAR, molecular dynamics simulation, and pharmacophore modelling studies of α-keto-[1,2,4]-oxadiazoles. Yu CX; Tan JW; Rullah K; Imran S; Tham CL J Biomol Struct Dyn; 2023; 41(22):12978-12996. PubMed ID: 36709457 [TBL] [Abstract][Full Text] [Related]
19. Identification of potent aldose reductase inhibitors as antidiabetic (Anti-hyperglycemic) agents using QSAR based virtual Screening, molecular Docking, MD simulation and MMGBSA approaches. Bakal RL; Jawarkar RD; Manwar JV; Jaiswal MS; Ghosh A; Gandhi A; Zaki MEA; Al-Hussain S; Samad A; Masand VH; Mukerjee N; Nasir Abbas Bukhari S; Sharma P; Lewaa I Saudi Pharm J; 2022 Jun; 30(6):693-710. PubMed ID: 35812153 [TBL] [Abstract][Full Text] [Related]
20. Structural Investigation of Vinca Domain Tubulin Binders by Pharmacophore, Atom based QSAR, Docking and Molecular Dynamics Simulations. Athar M; Lone MY; Khedkar VM; Radadiya A; Shah A; Jha PC Comb Chem High Throughput Screen; 2017; 20(8):682-695. PubMed ID: 28486912 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]